Bridgefront Capital’s Encompass Health EHC Stock Holding History

Bridgefront Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,770	Closed	-$1.04M	–	595
2025 Q4	$1.04M	Buy	9,770 +4,692	+92%	+$544K	0.26%	131
2025 Q3	$645K	Sell	5,078 -364	-7%	-$43.3K	0.19%	178
2025 Q2	$667K	Buy	+5,442	New	+$622K	0.18%	199
2023 Q3	–	Sell	-3,821	Closed	-$259K	–	446
2023 Q2	$259K	Buy	+3,821	New	+$239K	0.14%	310
2022 Q3	–	Sell	-7,886	Closed	-$352K	–	352
2022 Q2	$352K	Buy	+7,886	New	+$405K	0.39%	91
2021 Q4	–	Sell	-6,305	Closed	-$376K	–	349
2021 Q3	$376K	Buy	6,305 +1,828	+41%	+$115K	0.39%	78
2021 Q2	$278K	Sell	4,477 -10,300	-70%	-$687K	0.1%	375
2021 Q1	$963K	Buy	+14,777	New	+$964K	0.3%	66

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bridgefront Capital's EHC Position: Q1 2026 in Review

Bridgefront Capital sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 9,770 shares — an estimated $1.04M sold.

Bridgefront Capital first reported a position in EHC in Q1 2021 and held it in 8 quarters. The position peaked at $1.04M in Q4 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Bridgefront Capital reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
Bridgefront Capital sold 9,770 Encompass Health shares in Q1 2026, an estimated $1.04M.
Bridgefront Capital first reported a position in Encompass Health in Q1 2021 and held it in 8 quarters.
Bridgefront Capital's Encompass Health position peaked at $1.04M in Q4 2025.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.